<DOC>
	<DOCNO>NCT00062543</DOCNO>
	<brief_summary>The primary objective determine whether donor stem cell administer via hepatic artery infusion produce liver cell patient severe hepatic dysfunction post stem cell transplantation ( SCT ) safety procedure . The secondary objective improve liver function improve survival .</brief_summary>
	<brief_title>Hepatic Artery Infusion CD34+ Cells</brief_title>
	<detailed_description>Participants study received stem cell transplantation . As result procedure , participant develop severe liver dysfunction . Researchers recently discover cell circulate blood bone marrow capable forming liver cell . Before take part study , woman able child must negative blood pregnancy test . Participants study donor 's cell infuse directly liver catheter insert groin . This do liver disease diagnose liver biopsy . The catheter stay groin 3 day . During time , participant expose repeat x-ray exam ensure catheter stays place . During time catheter place , infusion repeat long donor 's cell available . Participants receive different drug vein decrease risk transfusion reaction . After complete donor cell infusion , catheter remove . After participant release hospital , periodic evaluation liver size . About 1 teaspoon blood draw standard blood test evaluate liver function . Around Days 28 90 , participant liver biopsy . This investigational study . A total 10 patient take part study . All enrol UTMDACC .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>SCT recipient severe hepatic dysfunction ( bilirubin equal great 5mg/dl ) histologically document VOD . The original stem cell donor must sexmismatched , willing able donate GCSFmobilized peripheral blood stem cell . The patient must complete donor chimerism . Patients least 5 x 10^6 donor CD34+ cells/kg available infusion . Patients graft versus host disease ( GVHD ) . Patients hepatic artery infusion perform anatomical technical reason . Patients active hepatitis B C .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Severe hepatic dysfunction post stem cell transplantation</keyword>
	<keyword>Stem Cell Transplantation</keyword>
	<keyword>Hepatic Artery Infusion</keyword>
	<keyword>Liver Diseases</keyword>
	<keyword>CD34+ Cells</keyword>
	<keyword>SCT</keyword>
</DOC>